A detailed history of Milestone Resources Group LTD transactions in Abbott Laboratories stock. As of the latest transaction made, Milestone Resources Group LTD holds 940,458 shares of ABT stock, worth $111 Million. This represents 3.73% of its overall portfolio holdings.

Number of Shares
940,458
Previous 940,458 -0.0%
Holding current value
$111 Million
Previous $97.7 Million 9.72%
% of portfolio
3.73%
Previous 3.35%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

BUY
$100.73 - $112.44 $4.67 Million - $5.21 Million
46,321 Added 5.18%
940,458 $97.7 Million
Q3 2023

Nov 09, 2023

SELL
$95.53 - $114.62 $190,295 - $228,323
-1,992 Reduced 0.22%
894,137 $86.6 Million
Q1 2023

Apr 14, 2023

SELL
$96.86 - $114.01 $55,985 - $65,897
-578 Reduced 0.06%
896,129 $90.7 Million
Q1 2022

Apr 26, 2022

SELL
$114.02 - $139.04 $348,331 - $424,767
-3,055 Reduced 0.34%
896,707 $106 Million
Q3 2021

Oct 22, 2021

BUY
$116.66 - $129.06 $46,547 - $51,494
399 Added 0.04%
899,762 $106 Million
Q2 2021

Aug 02, 2021

BUY
$105.79 - $124.53 $9.05 Million - $10.7 Million
85,592 Added 10.52%
899,363 $104 Million
Q1 2021

Apr 30, 2021

BUY
$108.84 - $128.23 $3.88 Million - $4.57 Million
35,676 Added 4.59%
813,771 $97.5 Million
Q4 2020

Feb 01, 2021

BUY
$105.0 - $114.42 $38.4 Million - $41.9 Million
365,784 Added 88.72%
778,095 $85.2 Million
Q3 2020

Oct 09, 2020

BUY
$91.64 - $111.29 $13.3 Million - $16.2 Million
145,289 Added 54.41%
412,311 $44.9 Million
Q2 2020

Aug 10, 2020

SELL
$76.57 - $98.0 $49.1 Million - $62.8 Million
-641,202 Reduced 70.6%
267,022 $24.4 Million
Q1 2020

May 05, 2020

BUY
$62.82 - $91.86 $19.1 Million - $27.9 Million
304,084 Added 50.33%
908,224 $71.7 Million
Q4 2019

Jan 24, 2020

BUY
$78.51 - $87.4 $47.4 Million - $52.8 Million
604,140 New
604,140 $52.5 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Milestone Resources Group LTD Portfolio

Follow Milestone Resources Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Milestone Resources Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Milestone Resources Group LTD with notifications on news.